Method of detection of alterations in MSH5

Details Method of detection of alterations in MSH5 Method of detection of alterations in MSH5

1999-12-22

2003-12-30

Fredman, Jeffrey (Department: 1634)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S024300, C536S024310, C536S024330, C514S04400A, C435S006120

Reexamination Certificate

active

06670460

ABSTRACT:

FIELD OF THE INVENTION
The present invention pertains to a mammalian DNA mismatch repair gene, MSH5, and uses thereof, for example, in drug screening, cancer prognosis and diagnosis. The gene product is required for meiotic crossing over and segregation of chromosomes during meiosis. More specifically, the invention relates to detection of alterations in the gene which are associated with some mammalian, preferably human, cancers, as well as conditions involving problems in meiotic segregation.
BACKGROUND OF THE INVENTION
Accurate transmission of genetic information is important in the survival of a cell, an organism, and a species. A number of mechanisms have evolved that help to ensure high fidelity transmission of genetic material from one generation to the next since mutations can lead to new genotypes that may be deleterious to the cell. DNA lesions that frequently lead to mutations are modified, missing or mismatched nucleotides. Multiple enzymatic pathways have been described in prokaryotic systems that can specifically repair these lesions.
There are at least three ways in which mismatched nucleotides arise in DNA. First, physical damage to the DNA or DNA precursors can give rise to mismatched bases in DNA. For example, the deamination of 5-methyl-cytosine creates a thymine and, therefore, a G-T mispair. Second, misincorporation, insertion, or deletion of nucleotides during DNA replication can yield mismatched base pairs. Finally, genetic recombination produces regions of heteroduplex DNA which may contain mismatched nucleotides when such heteroduplexes result from the pairing of two different parental DNA sequences. Mismatched nucleotides produced by each of these mechanisms are known to be repaired by specific enzyme systems.
The well defined mismatch repair pathway is the
E. coli
MutHLS pathway that promotes a long-patch (approximately 3 Kb) excision repair reaction which is dependent on the mutH, mutL, mutS and MutU(uvrD) gene products. The MutHLS pathway appears to be the most active mismatch repair pathway in
E. coli
and is known to both increase the fidelity of DNA replication and act on recombination intermediates containing mispaired bases. This system has been reconstituted in vitro and requires the MutH, MutL, MutS and UvrD (helicase II) proteins along with DNA polymerase III holoenzyme, DNA ligase, single-stranded DNA binding protein (SSB) and one of the single-stranded DNA exonucleases, Exo I, Exo VII or RecJ. MutS protein binds to the mismatched nucleotides in DNA. MutH protein interacts with GATC sites in DNA that are hemi-methylated on the A and is responsible for incision on the unmethylated strand. Specific excision of the unmethylated strand results in increased fidelity of replication because excision is targeted to the newly replicated unmethylated DNA strand. MutL facilitates the interaction between MutS bound to the mismatch and MutH bound to the hemi-methylated Dam site resulting in the activation of MutH. UvrD is the helicase that appears to act in conjunction with one of the single-stranded DNA specific exonucleases to excise the unmethylated strand leaving a gap which is repaired by the action of DNA polymerase III holoenzyme, SSB and DNA ligase. In addition,
E. coli
contains several short patch repair pathways including the VSP system and the MutY (MicA) system that act on specific single base mispairs.
In bacteria, therefore, mismatch repair plays a role in maintaining the genetic stability of DNA. The bacterial MutHLS system has been found to prevent genetic recombination between the divergent DNA sequences of related species such as
E. coli
and
S. typhimurium
(termed: homologous recombination).
A number of human mismatch repair genes have been discovered. Defects in the human MSH2 gene are associated with Hereditary Non-Polyposis Colon Cancer (HNPCC), a familiar form of human colorectal cancer (CRC) that is also known as Lynch's Syndrome. Other mismatch repair genes discovered in humans include MLH 1.
These genes are not only involved with susceptibility to cancer, but can be associated with other aspects. For example, defects in MSH2 and MLH1 confer resistance to alkylating agents frequently used in treating cancers. Consequently, the discovery of mismatch repair genes is extremely important. For example, finding a new mismatch repair gene permits one to look for defects in that gene and determine its association with particular cancers. This not only permits one to determine susceptibility to particular cancers, but to have a better prognosis of the disease and to more fully understand what therapies to use. Thus, being able to fmd additional mammalian, particularly human, mismatch repair genes is very important.
SUMMARY OF THE INVENTION
We have discovered and sequenced mammalian MSH5 genes which are involved in the DNA mismatch repair pathway. We have identified its chromosomal location in humans as well as the intron-exon borders in both mice and humans. This gene produces a protein involved in meiotic crossing over and segregation of chromosomes during meiosis. Thus, defects in the gene should indicate susceptibility to disorders associated with those activities such as Downs Syndrome and certain types of infertility. Further defects in mismatch repair genes indicate susceptibility to various types of cancer. Moreover, defects in this gene confer resistance to alkylating agents. Alkylating agents represent a preferred class of chemotherapeutic agents frequently used in treating cancer.
Consequently, individuals diagnosed with cancer should have that cancer screened for the presence of a defect in the MSH5 gene. If the individual has such a defect, then an agent other than an alkylating agent should be prescribed. This gene, also has other applications. It can be used in assays, to express gene product, for drug screens, and therapeutically.
DESCRIPTION OF THE SEQUENCE LISTING
SEQ ID NO.:1 is the nucleotide sequence of the human MSH5 MSH2 gene.
SEQ ID NO.:2 is the deduced amino acid sequence of the human MSH5 gene product.
SEQ ID NOs.:3-26 are the nucleotide sequence of the 5=exon-intron borders.
SEQ ID NOs:27-50 are the nucleotide sequences of the 3=intron-exon borders.
SEQ ID NOs: 51 and 52 are primers used in screening for human genomic MSH5.
SEQ ID NO:53 is the nucleotide sequence of the murine MSH5 gene.
SEQ ID NO:54 is the deduced amino acid sequence of the murine MSH5 gene product.
SEQ ID NOs:55-85 represent nucleotide intronic sequences of human MSH5.
SEQ ID NOs:86-90 are nucleotide sequences of the 5′ exon-intron borders of mMSH5.
SEQ ID NOs:91-95 are nucleotide sequences of the 3′ intron-exon borders of mMSH5.
SEQ ID NOs:96-100 represent nucleotide intronic sequences of murine MSH5.
SEQ ID NOs:101-104 are primers used.


REFERENCES:
patent: 5710037 (1998-01-01), Vanin et al.
patent: 6025192 (2000-02-01), Beach et al.
patent: 297 379 (1987-06-01), None
patent: WO 95/14085 (1995-05-01), None
patent: WO 95/15381 (1995-06-01), None
patent: WO 95/16793 (1995-06-01), None
patent: WO 96/41192 (1996-12-01), None
Genbank Accession No. Z57284, Cross et al, Oct. 18, 1995.*
Sargent et al, “Identification of multiple HTF-island associated genes in the human major histocompatibility complex class III region,” EMBO J. 8(8):2305-2312, Aug. 1989.*
Albertella et al, “Localization of eight additional genes in the human major histocompatability complex, including the gene encoding the casein kinase II b subunit (CSN2b)”, Genomics 36:240-251, Sep. 1996.*
Hillier et al (1995) Genbank Accesion No. T67203.*
Lage et al, “Cloning of a human cDNA encoding a protein with high homology to yeast methionyl-tRNA synthetase”, Gene (1996) 178:187-189.*
N. M. Hollingsworth et al., “MSH5, A Novels MUTS Homolog, Facilitates Meiotic Reciprocal Recombination Between Homologs InSaccharomyces CerevisiaeBut Not Mismatch Repair,”Genes and Development, 9(14):1728-1739, 1995.
S. Acharya et al., “hMSH2 Forms Specific Mispair-Binding Complexes with hMSH3 and hMSH6,”Proc. Natl. Acad. Sci.USA, 93:13629-13634, 1996.
B. Liu et al., “

Affiliated with

Also associated with

Rating

Method of detection of alterations in MSH5 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of detection of alterations in MSH5, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detection of alterations in MSH5 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3172920